SC
BHC icon

Schubert & Co’s Bausch Health BHC Stock Holding History

Schubert & Co’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-34
Closed – – 1381
2022
Q2 		$0 Buy
+34
New +$475 ﹤0.01% 1443

Other funds holding BHC

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return

Schubert & Co's BHC Position: Q3 2022 in Review

Schubert & Co sold out of Bausch Health (BHC) in Q3 2022, closing a stake of 34 shares.

Schubert & Co first reported a position in BHC in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 283 funds tracked by Wall St. Rank hold BHC as of Q3 2022.

  • Schubert & Co reported no remaining Bausch Health position as of Q3 2022 after selling out during the quarter.
  • Schubert & Co sold 34 Bausch Health shares in Q3 2022.
  • Schubert & Co first reported a position in Bausch Health in Q2 2022 and held it in 1 quarter.
  • Schubert & Co's Bausch Health position peaked at $0 in Q2 2022.
  • 283 funds tracked by Wall St. Rank held Bausch Health as of Q3 2022.

Based on Schubert & Co's 13F filing for Q3 2022, filed 21 Oct 2022.